Search

David J Fairfax

from Slingerlands, NY
Age ~57
Get Report
Also known as:
David Michele Fairfax, Dave J Fairfax
Phone and address:
72 Mccormack Rd, Slingerlands, NY 12159
(518) 439-6790
Related to:
Donald P Fairfax, 44Carl L Fairfax, 27
Connected to:
Ben F Fairfax, 81Cheryl M Fairfax, 66Corey J Fairfax, 35Jonathan E Fairfax, 37Laura M Fairfax, 90Marvenia L Fairfax, 58Elaine M Fairfield, 72Eleanor D Fairfield, 108Keegan Fairfield, 32Lauren D Fairfield, 53

David Fairfax Phones & Addresses

  • 72 Mccormack Rd, Slingerlands, NY 12159 (518) 439-6790
  • Rensselaer, NY
  • 163 Adams St, Delmar, NY 12054 (518) 439-6790
  • 101 Heritage Rd, Guilderland, NY 12084 (518) 869-5571
  • Nyack, NY
  • Worcester, PA
  • Albany, NY

Work

Position: Administration/Managerial

Resumes

Resumes

David Fairfax Photo 1

President And Ceo, Kinentia Biosciences

View page
Position:
President and CEO at Kinentia Biosciences
Location:
Albany, New York Area
Industry:
Pharmaceuticals
Work:
Kinentia Biosciences - Albany, NY since Nov 2007
President and CEO
AMRI 1996 - 2007
Director, Medicinal Chemistry
Education:
Imperial College London 1985 - 1988
BSc, Chemistry Imperial College London 1988 - 1991
PhD, Chemistry Emory University 1991 - 1993
Post-Doctoral Research Associate, Organic Chemistry
Skills:
Medicinal Chemistry
Pharmaceutical Industry
CRO
Global R&D
Project Management
Organic Synthesis
Chemistry
Drug Design
Drug Discovery
Organic Chemistry
Drug Development
Technology Transfer
David Fairfax Photo 2

David Fairfax

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
David Fairfax
President, Partner
Kinentia Biosciences LLC
Pharmaceutical Research and Development
9 University Pl, Defreestville, NY 12144
(518) 256-1202

Publications

Us Patents

Parp Inhibitors

View page
US Patent:
6924284, Aug 2, 2005
Filed:
Aug 15, 2002
Appl. No.:
10/222749
Inventors:
Graham Beaton - Poway CA, US
Wilna J. Moree - San Diego CA, US
Jaimie K. Rueter - San Diego CA, US
Russell S. Dahl - Carlsbad CA, US
David L. McElligott - Bothell WA, US
Phyllis Goldman - Bothell WA, US
Anthony J. Demaggio - Kenmore WA, US
Erik Christenson - Bellevue WA, US
Dan Herendeen - Kirkland WA, US
Kerry W. Fowler - Seattle WA, US
Danwen Huang - Sammamish WA, US
Jaimie E. Bertino - Guilderland NY, US
Lisa H. Bourdon - Latham NY, US
David J. Fairfax - Delmar NY, US
Qin Jiang - Latham NY, US
Helge A. Reisch - Rensselaer NY, US
Ren Hua Song - Latham NY, US
Pavel E. Zhichkin - Latham NY, US
Assignee:
ICOS Corporation - Bothell WA
Deltagen Research Labs, LLC - San Diego CA
International Classification:
C07D413/14
C07D413/12
C07D237/52
A61K031/5377
A61K031/502
US Classification:
5142345, 514248, 544116, 544235, 544236, 544237
Abstract:
The present invention provides compounds comprising a bicyclic aryl moiety, such as 2H-phthalazin-1-one or derivatives thereof, compositions comprising the same, and methods for producing and using the same. In particular, the present invention provides compounds of the formula: or a pharmaceutically acceptable salt, a hydrate, a solvate, or a prodrug thereof; where Q, Qand Y are those defined herein.

Benzoxazole Carboxamides For Treating Cinv And Ibs-D

View page
US Patent:
7307094, Dec 11, 2007
Filed:
Feb 17, 2006
Appl. No.:
11/357494
Inventors:
David J. Fairfax - Slingerlands NY, US
Zhicai Yang - Schenectady NY, US
Assignee:
AMR Technology, Inc. - Manchester VT
International Classification:
A61K 31/423
C07D 263/57
US Classification:
514375, 548224
Abstract:
Compounds of formulae I and II:.

Tricycloundecane Compounds Useful As Modulators Of Nuclear Hormone Receptor Function

View page
US Patent:
7550458, Jun 23, 2009
Filed:
Oct 17, 2006
Appl. No.:
11/581873
Inventors:
James Aaron Balog - Lambertville NJ, US
David John Fairfax - Slingerlands NY, US
Gregory Scott Martin - Guilderland NY, US
Mark E. Salvati - Lawrenceville NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 491/14
C07D 471/14
A61K 31/5383
A61K 31/4745
US Classification:
5142298, 544101
Abstract:
Tricycloundecanes compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds are disclosed.

Soluble 1,4 Benzodiazepine Compounds And Stable Salts Thereof

View page
US Patent:
7759338, Jul 20, 2010
Filed:
Apr 26, 2007
Appl. No.:
11/796039
Inventors:
Manzer Durrani - Scottsdale AZ, US
William B. Geiss - Athens NY, US
David J. Fairfax - Slingerlands NY, US
Dmytro O. Tymoshenko - Albany NY, US
Van-Duc Le - Selkirk NY, US
Lisa Helen Peterson - Schenectady NY, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 31/5513
A61P 35/00
C07D 243/18
US Classification:
514221, 540504, 540512
Abstract:
The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and related compounds and methods of using benzodiazepine derivatives and related compounds as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, hyperproliferation, and the like.

Benzoxazole Carboxamides For Treating Cinv And Ibs-D

View page
US Patent:
7781430, Aug 24, 2010
Filed:
Nov 2, 2007
Appl. No.:
11/934523
Inventors:
David J. Fairfax - Slingerlands NY, US
Zhicai Yang - Schenectady NY, US
Assignee:
Albany Molecular Research, Inc. - Albany NY
International Classification:
A61K 31/5377
A61K 31/423
A61K 31/4523
A61K 31/443
A61K 31/4375
A61K 31/439
A61P 1/00
C07D 401/14
C07D 413/00
C07D 453/00
US Classification:
5142332, 51425304, 514304, 514305, 514321, 514375, 544127, 544362, 546126, 546133, 546198, 548224
Abstract:
Compounds of formulae I and II:.

Compounds For The Treatment Of Spinal Muscular Atrophy And Other Uses

View page
US Patent:
8110681, Feb 7, 2012
Filed:
Mar 13, 2007
Appl. No.:
12/293268
Inventors:
Jill Heemskerk - Bethesda MD, US
Keith D. Barnes - Rexford NY, US
John M. McCall - Boca Grande FL, US
Graham Johnson - Madison CT, US
David Fairfax - Slingerlands NY, US
Matthew Robert Johnson - Morrisville NC, US
Assignee:
The United States of America as represented by the Secretary, Department of Health and Human Services - Washington DC
Albany Molecular Research, Inc. - Albany NY
Science Applications International Inc. (SAIC) - San Diego CA
International Classification:
C07D 413/04
C07D 239/24
C07D 401/04
C07D 209/46
C07D 206/56
A61K 31/535
A61K 31/44
A61K 31/40
A01N 43/54
US Classification:
544144, 544242, 5462771, 548472, 548450, 5142352, 514256, 514339, 514414, 514416
Abstract:
Compounds of Formula (I) or (II) useful for the treatment of spinal muscular atrophy or other uses, as well as methods of using such compounds to increase SMN expression, increase EAAT2 expression, or increase the expression of a nucleic acid that encodes a translational stop codon introduced by mutation or frameshift.

Novel Soluble 1,4 Benzodiazepine Compounds And Stable Salts Thereof

View page
US Patent:
20110009393, Jan 13, 2011
Filed:
Jul 19, 2010
Appl. No.:
12/838565
Inventors:
Manzer Durrani - Scottsdale AZ, US
William B. Geiss - Athens NY, US
David J. Fairfax - Slingerlands NY, US
Dmytro O. Tymoshenko - Albany NY, US
Van-Duc Le - Selkirk NY, US
Lisa H. Peterson - Schenectady NY, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor
International Classification:
A61K 31/5513
C07D 243/24
A61P 37/00
A61P 29/00
A61P 35/00
A61P 35/02
A61P 17/06
A61P 11/06
A61P 37/06
US Classification:
514221, 540504
Abstract:
The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and related compounds and methods of using benzodiazepine derivatives and related compounds as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, hyperproliferation, and the like.

Novel Soluble 1,4 Benzodiazepine Compounds And Stable Salts Thereof

View page
US Patent:
20110245238, Oct 6, 2011
Filed:
Jun 17, 2011
Appl. No.:
13/162731
Inventors:
Manzer Durrani - Scottsdale AZ, US
William B. Geiss - Athens NY, US
David J. Fairfax - Slingerlands NY, US
Dmytro O. Tymoshenko - Albany NY, US
Van-Duc Le - Selkirk NY, US
Lisa H. Peterson - Schenectady NY, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 31/5513
C07D 413/12
C07D 243/24
A61P 35/00
A61P 11/06
A61P 17/06
A61P 37/06
US Classification:
514221, 540504
Abstract:
The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and related compounds and methods of using benzodiazepine derivatives and related compounds as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, hyperproliferation, and the like.
Control profile
David J Fairfax from Slingerlands, NY, age ~57 Get Report